Only One of These Stocks Won't Be a Winner
These stocks just rolled over. Which ones will bounce back?
What Is This CEO Doing to Earn $450 Per Hour?
Geron's CEO gets called out on an analyst call.
Wall Street Is Out of Patience With This Biotech
Cancer drug hopeful Geron gets hit with a downgrade.